Literature DB >> 722741

Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form.

Y Kidani, K Inagaki, M Iigo, A Hoshi, K Kuretani.   

Abstract

Platinum complexes derived from three isomers of 1,2-diaminocyclohexane have been synthesized and their antitumor activities were evaluated against ascites Sarcoma-180. All the platinum complexes had high antitumor activity. Platinum complexes derived from cis-1,2-diaminocyclohexane were more effective than those derived from trans-l-and trans-d-1,2-diaminocyclohexane. Among the platinum complexes tested, oxalato(cis-1,2-diminocyclohexane)platinum had a remarkably high therapeutic index. Modification of the nonleaving group as well as that of the leaving group is important in order to find better antitumor platinum complexes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 722741     DOI: 10.1021/jm00210a029

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  36 in total

1.  Biological activity of enantiomeric complexes [PtCl(2)L (2)] (L (2) is aromatic bisphosphanes and aromatic diamines).

Authors:  Sophie Bombard; Marzia Bruna Gariboldi; Elena Monti; Elisabetta Gabano; Luca Gaviglio; Mauro Ravera; Domenico Osella
Journal:  J Biol Inorg Chem       Date:  2010-03-24       Impact factor: 3.358

Review 2.  Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery.

Authors:  Kensuke Osada; R James Christie; Kazunori Kataoka
Journal:  J R Soc Interface       Date:  2009-04-01       Impact factor: 4.118

3.  Synthesis and antitumor activity of a series of (aminoethylpyrrolidine) platinum complexes.

Authors:  A R Khokhar; D B Brown; J J McCormack; M P Hacker
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting.

Authors:  Katherine S Lovejoy; Stephen J Lippard
Journal:  Dalton Trans       Date:  2009-10-01       Impact factor: 4.390

5.  The Crystal Structure of Oxaliplatin: A Case of Overlooked Pseudo Symmetry.

Authors:  Timothy C Johnstone
Journal:  Polyhedron       Date:  2014-01-08       Impact factor: 3.052

6.  Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways.

Authors:  Kogularamanan Suntharalingam; Timothy C Johnstone; Peter M Bruno; Wei Lin; Michael T Hemann; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2013-09-16       Impact factor: 15.419

7.  Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes.

Authors:  Z H Siddik; S al-Baker; G Thai; A R Khokhar
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

8.  Phase I study of oxaliplatin in patients with advanced cancer.

Authors:  J M Extra; M Espie; F Calvo; C Ferme; L Mignot; M Marty
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

9.  Differential antitumor activity and toxicity of isomeric 1,2-diaminocyclohexane platinum (II) complexes.

Authors:  Z H Siddik; S al-Baker; T L Burditt; A R Khokhar
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Preparation of mammalian expression vectors incorporating site-specifically platinated-DNA lesions.

Authors:  Wee Han Ang; William Wesley Brown; Stephen J Lippard
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.